FIELD: medicine.
SUBSTANCE: what is presented is using neuroleptic spiperone as an agent able to prevent developing disorders in pulmonary tissue caused by cytostatic bleomycin administered.
EFFECT: anti-inflammatory and antifibrotic action of spiperone is presented on simulated reversible and irreversible pulmonary fibrosis caused by bleomycin with reducing a degree of alveocyte desquamation and delaying pulmonary tissue destruction.
2 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR PNEUMOFIBROSIS PREVENTION AND TREATMENT AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2646810C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2012 |
|
RU2479312C1 |
| METHOD OF TREATING PULMONARY FIBROSIS | 2012 |
|
RU2494470C1 |
| METHOD FOR IMPROVING THERAPEUTIC EFFECTIVENESS IN LUNG TISSUE DISORDERS AFTER ACTION OF CYTOSTATICS | 2012 |
|
RU2497523C1 |
| AGENT PREVENTING DEVELOPING DISORDERS IN PULMONARY TISSUE AND BLOOD SYSTEM ACCOMPANYING CYTOSTATIC ACTION | 2011 |
|
RU2464983C1 |
| PREPARATION PREVENTING DEVELOPMENT OF ABNORMALITIES IN LUNG TISSUE UNDER CYTOSTATIC IMPACT | 2011 |
|
RU2455991C1 |
| METHOD FOR PRODUCING AND INDUCING TARGETED DIFFERENTIATION OF PULMONARY PLURIPOTENT CELL CULTURE | 2013 |
|
RU2554843C2 |
| AGENT FOR CORRECTING PULMONARY TISSUE DISORDERS UNDER CYTOSTATIC EXPOSURE | 2013 |
|
RU2554776C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| MEDICINAL AGENT STIMULATING PULMONARY ENDOTHELIAL REGENERATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2740378C1 |
